Watchlist Price Alert

Acer Therapeutics Inc. (ACER)

NASDAQ: ACER · Real-Time Price · USD

0.66

-0.14 (-17.96%)

At close: Nov 20, 2023, 8:59 PM

Acer Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-26.24M	-15.37M	-22.89M	-29.42M	-21.28M	-14.19M	-7.98M
Depreciation & Amortization	66.03K	70.91K	70.81K	58.28K	27.74K	4K	238.13K
Stock-Based Compensation	1.84M	2.29M	2.22M	2.61M	1.32M	418.09K	63.80
Other Working Capital	-9.81M	20.49M	1.97M	-2.34M	2.41M	-282.34K	-2.87M
Other Non-Cash Items	1.48M	-568.91K	359.23K	57.58K	4.67K	246.96K	1.77M
Deferred Income Tax	n/a	n/a	122.58K	n/a	n/a	2.08K	n/a
Change in Working Capital	-7.4M	13.45M	3.08M	-2.82M	3.35M	-569.88K	-3.24M
Operating Cash Flow	-30.25M	-134.91K	-17.03M	-29.51M	-16.59M	-14.1M	-9.2M
Capital Expenditures	-171.17K	-54.94K	-10.9K	-178.97K	-95.63K	-62.84K	-1.22K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	1.03M	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-54.94M	-10.9B	-95.63B	967.28K	1.03K	n/a
Investing Cash Flow	-171.17K	-54.94K	-10.9K	-178.97K	-95.63K	967.28K	-1.22K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	20.04M	7.14M	10.72M	92.27	42.71M	26.94M	65.43K
Financial Cash Flow	20.04M	7.14K	10.72M	92.27	42.71K	26.94M	65.43K
Net Cash Flow	-10.38M	6.95M	-6.32M	-29.59M	26.03M	13.81M	-9.14M
Free Cash Flow	-30.42M	-189.85K	-17.04M	-29.69M	-16.68M	-14.16M	-9.2M